在瘤学之外的HSP90抑制剂:在非瘤学疾病中的优化和机制见解
Xingyu Yin1, Huangliang Shu1, Danni Wang1
1State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
热冲击蛋白90 (HSP90) 抑制剂在治疗诸如感染和神经退行性疾病等非瘤性疾病方面表现有前途. 对优化抑制剂设计和机制的进一步研究是必要的,以实现它们的全部治疗潜力.
科学领域:
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 热冲击蛋白90 (HSP90) 对于细胞蛋白质稳定至关重要,有助于蛋白质折叠和成熟.
- 在瘤学中,HSP90抑制剂得到了充分的研究,但它们在非瘤学领域的应用尚未得到充分研究.
- 本综述系统地讨论了非癌症疾病的HSP90抑制剂.
研究的目的:
- 审查HSP90抑制剂在非瘤性疾病中的治疗潜力.
- 分析最近在抑制剂优化和信号通路方面的进展.
- 提出克服临床翻译挑战的策略.
主要方法:
- 在病毒/真菌感染,炎症疾病和神经退行性疾病中对HSP90抑制剂的文献综述.
- 对信号通路和HSP90-客户端蛋白相互作用的分析.
- 检查抑制剂优化和临床翻译策略.
主要成果:
- HSP90抑制剂在治疗病毒感染,真菌感染,炎症和神经退行性疾病方面表现出潜力.
- 最近的进展包括优化的抑制剂设计和对信号通路的更深入理解.
- 确定了非瘤学指示的临床翻译方面的挑战.
结论:
- HSP90抑制剂提供了超越癌症的治疗可能性,特别是对于传染病和神经退行性疾病.
- 优化的抑制剂设计和增强的机制理解是释放其潜力的关键.
- 建议采取战略方法,以促进这些适应症的临床转化.
更多相关视频
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Published on: March 31, 2022
06:51Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
相关概念视频
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Drug Discovery: Overview
Targeted Cancer Therapies
There are several types of targeted therapies against...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
